{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:36:31Z","timestamp":1778675791262,"version":"3.51.4"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Hereditary cancer syndromes predispose to several types of cancer due to inherited pathogenic variants in susceptibility genes. We describe the case of a 57-year-old woman, diagnosed with breast cancer, and her family. The proband belongs to a family with a suspected tumor syndrome, due to other cancer cases in her family from the paternal and maternal sides. After oncogenetic counseling, she was subjected to mutational analysis with an NGS panel analyzing 27 genes. The genetic analysis showed two monoallelic mutations in low penetrance genes, c.1187G&gt;A (p.G396D) in MUTYH and c.55dup (p.Tyr19Leufs*2) in BRIP1. One of the mutations was inherited from the maternal side and the other from the paternal side, suggesting two different cancer syndrome types in the family. MUTYH mutation was related to the onset of cancers on the paternal side, as confirmed by the occurrence of the same mutation in the proband\u2019s cousin. BRIP1 mutation was found in the proband\u2019s mother, indicating that it was related to the cancer cases observed on the maternal side, including breast cancer and sarcoma. Advances in NGS technologies have allowed the identification of mutations in families with hereditary cancers in genes other than those related to a specific suspected syndrome. A complete oncogenetic counseling, together with molecular tests that enable a simultaneous analysis of multiple genes, is essential for the identification of a correct tumor syndrome and for clinical decision-making in a patient and his\/her family. The detection of mutations in multiple susceptibility genes allows the initiation of early risk-reducing measures for identified mutation carriers among family members and to include them in a proper surveillance program for specific syndromes. Moreover, it may enable an adapted treatment for the affected patient, permitting personalized therapeutic options.<\/jats:p>","DOI":"10.3390\/genes14020428","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T03:57:16Z","timestamp":1675828636000},"page":"428","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes"],"prefix":"10.3390","volume":"14","author":[{"given":"Giovanna","family":"D\u2019Elia","sequence":"first","affiliation":[{"name":"Unity of Clinical and Molecular Pathology, AOU University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Caliendo","sequence":"additional","affiliation":[{"name":"Unity of Clinical and Molecular Pathology, AOU University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Passariello","sequence":"additional","affiliation":[{"name":"Unity of Clinical and Molecular Pathology, AOU University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Albanese","sequence":"additional","affiliation":[{"name":"Unity of Clinical and Molecular Pathology, AOU University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-3351","authenticated-orcid":false,"given":"Jasmine","family":"Makker","sequence":"additional","affiliation":[{"name":"Department of GKT, School of Medical Education, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Molinari","sequence":"additional","affiliation":[{"name":"Unity of Clinical and Molecular Pathology, AOU University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Vietri","sequence":"additional","affiliation":[{"name":"Unity of Clinical and Molecular Pathology, AOU University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2019). Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793. [No authors listed]. Obstet. Gynecol., 134, e143\u2013e149.","DOI":"10.1097\/AOG.0000000000003562"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cancergen.2020.04.074","article-title":"Double mutation of APC and BRCA1 in an Italian family","volume":"244","author":"Vietri","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Wu, H., Yu, Z., Li, L., Zhang, J., Liang, X., and Huang, Q. (2022). Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09943-0"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Vietri, M.T., Caliendo, G., D\u2019Elia, G., Resse, M., Casamassimi, A., Minucci, P.B., DelloIoio, C., Cioffi, M., and Molinari, A.M. (2020). Five Italian Families with Two Mutations in BRCA Genes. Genes, 11.","DOI":"10.3390\/genes11121451"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mrfmmm.2013.03.003","article-title":"Role of MUTYH in human cancer","volume":"743\u2013744","author":"Mazzei","year":"2013","journal-title":"Mutat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1897-4287-11-20","article-title":"The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients","volume":"11","author":"Wijnen","year":"2013","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"D\u2019Elia, G., Caliendo, G., Casamassimi, A., Cioffi, M., Molinari, A.M., and Vietri, M.T. (2018). APC and MUTYH Analysis in FAP Patients: A Novel Mutation in APC Gene and Genotype-Phenotype Correlation. Genes, 9.","DOI":"10.3390\/genes9070322"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/path.5829","article-title":"Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis","volume":"256","author":"Barreiro","year":"2022","journal-title":"J. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5306\/wjco.v11.i7.428","article-title":"MUTYH: Not just polyposis","volume":"11","author":"Curia","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","article-title":"Hereditarybreast and ovariancancer (HBOC): Review of its molecular characteristics, screening, treatment, and prognosis","volume":"28","author":"Yoshida","year":"2021","journal-title":"Breast Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Samuel, D., Diaz-Barbe, A., Pinto, A., Schlumbrecht, M., and George, S. (2022). Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2. Cells, 11.","DOI":"10.3390\/cells11030539"},{"key":"ref_13","first-page":"1","article-title":"The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients","volume":"1292","author":"Saleem","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.955","article-title":"Mutations in BRIP1 confer high risk of ovarian cancer","volume":"43","author":"Rafnar","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_15","first-page":"1","article-title":"New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer","volume":"228\u2013229","year":"2018","journal-title":"Cancer Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s12094-019-02236-2","article-title":"Li-Fraumeni syndrome heterogeneity","volume":"22","author":"Gargallo","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.22559","article-title":"Germline TP53 Mutations and the Changing Landscape of Li-Fraumeni Syndrome","volume":"35","author":"Kamihara","year":"2014","journal-title":"Hum. Mutat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutationcarriers in the NCI LFS cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-011-1548-5","article-title":"Two new CHEK2 germline variants detected in breast cancer\/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations","volume":"130","author":"Manoukian","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ejhg.2017.134","article-title":"The wide spectrum of POT1 gene variants correlates with multiple cancer types","volume":"25","author":"Calvete","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1515\/cclm-2013-0263","article-title":"Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family","volume":"51","author":"Vietri","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10689-015-9786-z","article-title":"Analysis of PALB2 in a cohort of Italian breast cancer patients: Identification of a novel PALB2 truncating mutation","volume":"14","author":"Vietri","year":"2015","journal-title":"Fam. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/or.2014.3685","article-title":"A novel PALB2 truncating mutation in an Italian family with male breast cancer","volume":"33","author":"Vietri","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: Recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/jhg.2016.132","article-title":"Type and frequency of MUTYH variants in Italian patients with suspected MAP: A retrospective multicenter study","volume":"62","author":"Ricci","year":"2017","journal-title":"J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.dnarep.2010.03.008","article-title":"Functional analysis of MUTYH mutated proteins associated with familial adenomatous polyposis","volume":"9","author":"Minoprio","year":"2010","journal-title":"DNA Repair"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12967-020-02391-z","article-title":"A comprehensive custom panel evaluation for routine hereditary cancer testing: Improving the yield of germline mutation detection","volume":"18","author":"Lastra","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zografos, E., Andrikopoulou, A., Papatheodoridi, A.M., Kaparelou, M., Bletsa, G., Liontos, M., Dimopoulos, M.A., and Zagouri, F. (2022). Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer. Genes, 13.","DOI":"10.3390\/genes13081362"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kamps, R., Brand\u00e3o, R.D., Bosch, B.J., Paulussen, A.D., Xanthoulea, S., Blok, M.J., and Romano, A. (2017). Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020308"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/ajg.2017.212","article-title":"Hereditary colorectal polyposis and cancer syndromes: A primer on diagnosis and management","volume":"112","author":"Kanth","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2217\/fon-2021-0286","article-title":"Molecular tests and target therapies in oncology: Recommendations from the Italian workshop","volume":"17","author":"Pinto","year":"2021","journal-title":"Future Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Montisci, A., Vietri, M.T., Palmieri, V., Sala, S., Donatelli, F., and Napoli, C. (2021). Cardiac Toxicity Associated with Cancer Immuno-therapy and Biological Drugs. Cancers, 13.","DOI":"10.3390\/cancers13194797"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/428\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:27:37Z","timestamp":1760120857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["genes14020428"],"URL":"https:\/\/doi.org\/10.3390\/genes14020428","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}